Anthony Petrone says the medical device sector may be moving past the worst of its downturn as valuations sit near multi-year lows. He points to procedure-volume pressure tied to the Affordable Care Act and Medicaid as key headwinds, but sees conditions improving into 2027 and low valuations potentially fueling M&A. Petrone also sees AI opportunities in cardiology and diagnostics, particularly for GE HealthCare (GEHC).